Download PDF
Am J Perinatol 2023; 40(16): 1803-1810
DOI: 10.1055/s-0041-1740007
Original Article

Oral Glucose Tolerance Test in Pregnancy and Subsequent Maternal Hypertension

Maged M. Costantine 
1   Departments of Obstetrics and Gynecology of University of Texas Medical Branch, Galveston, Texas
,
Madeline Murguia Rice
2   George Washington University Biostatistics Center, Washington, District of Columbia
,
Mark B. Landon
3   Departments of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio
,
Michael W. Varner 
4   Departments of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah
,
Brian M. Casey
5   Departments of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
,
Uma M. Reddy
6   Departments of Obstetrics and Gynecology, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, Maryland
,
Ronald J. Wapner
7   Departments of Obstetrics and Gynecology, Columbia University, New York, New York
,
Dwight J. Rouse
8   Departments of Obstetrics and Gynecology, Brown University, Providence, Rhode Island
,
Alan T.N. Tita
9   Departments of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
John M. Thorp
10   Departments of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
,
Edward K. Chien
11   Departments of Obstetrics and Gynecology, MetroHealth Medical Center-Case Western Reserve University, Cleveland, Ohio
,
Alan M. Peaceman
12   Departments of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois
,
Sean C. Blackwell
13   Departments of Obstetrics and Gynecology, University of Texas Health Science Center at Houston-Children's Memorial Hermann Hospital, Houston, Texas
,
for the Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network › Author Affiliations Funding The project described was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD27915, U10HD36801, HD34208, HD34116, HD40485, HD40500, HD27869, HD40560, HD40544, HD53097, HD40512, HD40545] and the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) [UL1TR001070, UL1TR000439]. Comments and views of the authors do not necessarily represent views of the NIH.
› Further Information
    Permissions and Reprints

Abstract

Objective The aim of the study is to evaluate whether values and the shape of the glucose curve during the oral glucose tolerance test (OGTT) in pregnancy identify women at risk of developing hypertension (HTN) later in life.

Study Design This category includes the secondary analysis of a follow-up from a mild gestational diabetes mellitus (GDM) study that included a treatment trial for mild GDM (n = 458) and an observational cohort of participants with abnormal 1-hour glucose loading test only (normal OGTT, n = 430). Participants were assessed at a median of 7 (IQR 6–8) years after their index pregnancy, and trained staff measured their blood pressure (systolic blood pressure [SBP]; diastolic blood pressure [DBP]). The association between values and the shape of the glucose curve during OGTT in the index pregnancy and the primary outcome defined as elevated BP (SBP ≥120, DBP ≥80 mm Hg, or receiving anti-HTN medications), and secondary outcome defined as stage 1 or higher (SBP ≥130, DBP ≥80 mm Hg, or receiving anti-HTN medications) at follow-up were evaluated using multivariable regression, adjusting for maternal age, body mass index, and pregnancy-associated hypertension during the index pregnancy.

Results There was no association between fasting, 1-hour OGTT, and the outcomes. However, the 2-hour OGTT value was positively associated (adjusted odds ratio [aRR] per 10-unit increase 1.04, 95% CI 1.01–1.08), and the 3-hour was inversely associated (aRR per 10-unit increase 0.96, 95% CI 0.93–0.99) with the primary outcome. When the shape of the OGTT curve was evaluated, a monophasic OGTT response (peak at 1 hour followed by a decline in glucose) was associated with increased risk of elevated BP (41.3vs. 23.5%, aRR 1.66, 95% CI 1.17–2.35) and stage 1 HTN or higher (28.5 vs. 14.7%, aRR 1.83, 95% CI 1.15–2.92), compared with a biphasic OGTT response.

Conclusion Among persons with mild GDM or lesser degrees of glucose intolerance, the shape of the OGTT curve during pregnancy may help identify women who are at risk of HTN later in life, with biphasic shape to be associated with lower risk.

Key Points

  • The shape of the Oral Glucose Tolerance Test curve may help identify patients who are at risk of having elevated BP or HTN 5 to 10 years following pregnancy.

  • The 2-hour Oral Glucose Tolerance Test values is positively associated with elevated BP 5 to 10 years following pregnancy.

  • This supports the concept of pregnancy as a window to future health and represents a potential novel biomarker for maternal cardiovascular health screening.

Keywords

gestational diabetes - glucose tolerance test - hypertension - elevated blood pressure

* The other members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network are listed in the [Supplementary Appendix A].


Supplementary Material



Publication History

Received: 18 April 2020

Accepted: 04 October 2021

Article published online:
16 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25 (10) 1862-1868
    CrossrefPubMedGoogle Scholar
  • 2 Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294 (21) 2751-2757
    CrossrefPubMedGoogle Scholar
  • 3 Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335 (7627): 974
    CrossrefPubMedGoogle Scholar
  • 4 Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002; 325 (7356): 157-160
    Google Scholar
  • 5 Committee on Practice B-O. ACOG Practice Bulletin No. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
    CrossrefPubMedGoogle Scholar
  • 6 Dabelea D, Hanson RL, Lindsay RS. et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000; 49 (12) 2208-2211
    CrossrefPubMedGoogle Scholar
  • 7 Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241 (19) 2035-2038
    CrossrefPubMedGoogle Scholar
  • 8 Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2 (02) 120-126
    CrossrefPubMedGoogle Scholar
  • 9 Fox CS, Coady S, Sorlie PD. et al. Trends in cardiovascular complications of diabetes. JAMA 2004; 292 (20) 2495-2499
    CrossrefPubMedGoogle Scholar
  • 10 Kim JY, Michaliszyn SF, Nasr A. et al. The shape of the glucose response curve during an oral glucose tolerance test heralds biomarkers of type 2 diabetes risk in obese youth. Diabetes Care 2016; 39 (08) 1431-1439
    CrossrefPubMedGoogle Scholar
  • 11 Carr DB, Utzschneider KM, Hull RL. et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006; 29 (09) 2078-2083
    CrossrefPubMedGoogle Scholar
  • 12 Mosca L, Benjamin EJ, Berra K. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. Circulation 2011; 123 (11) 1243-1262
    CrossrefPubMedGoogle Scholar
  • 13 Casey BM, Rice MM, Landon MB. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Effect of treatment of mild gestational diabetes on long-term maternal outcomes. Am J Perinatol 2020; 37 (05) 475-482
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Retnakaran R, Shah BR. Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol 2019; 7 (05) 378-384
    CrossrefPubMedGoogle Scholar
  • 15 Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B. Screening glucose challenge test in pregnancy can identify women with an adverse postpartum cardiovascular risk factor profile: implications for cardiovascular risk reduction. J Am Heart Assoc 2019; 8 (21) e014231
    CrossrefPubMedGoogle Scholar
  • 16 Manco M, Nolfe G, Pataky Z. et al. Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort. Metabolism 2017; 70: 42-50
    CrossrefPubMedGoogle Scholar
  • 17 Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?. Am J Physiol Regul Integr Comp Physiol 2011; 300 (04) R941-R948
    CrossrefPubMedGoogle Scholar
  • 18 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71 (19) e127-e248
    CrossrefPubMedGoogle Scholar
  • 19 Landon MB, Spong CY, Thom E. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
    CrossrefPubMedGoogle Scholar
  • 20 Landon MB, Rice MM, Varner MW. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Mild gestational diabetes mellitus and long-term child health. Diabetes Care 2015; 38 (03) 445-452
    CrossrefPubMedGoogle Scholar
  • 21 Tschritter O, Fritsche A, Shirkavand F, Machicao F, Häring H, Stumvoll M. Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 2003; 26 (04) 1026-1033
    CrossrefPubMedGoogle Scholar
  • 22 Retnakaran R. Hyperglycemia in pregnancy and its implications for a woman's future risk of cardiovascular disease. Diabetes Res Clin Pract 2018; 145: 193-199
    CrossrefPubMedGoogle Scholar
  • 23 Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 2019; 62 (06) 905-914
    CrossrefPubMedGoogle Scholar
  • 24 Daly B, Toulis KA, Thomas N. et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study. PLoS Med 2018; 15 (01) e1002488
    CrossrefPubMedGoogle Scholar
  • 25 Tobias DK, Stuart JJ, Li S. et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med 2017; 177 (12) 1735-1742
    CrossrefPubMedGoogle Scholar
  • 26 Kaul P, Savu A, Nerenberg KA. et al. Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis. Diabet Med 2015; 32 (02) 164-173
    CrossrefPubMedGoogle Scholar
  • 27 Fadl H, Magnuson A, Östlund I, Montgomery S, Hanson U, Schwarcz E. Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG 2014; 121 (12) 1530-1536
    CrossrefPubMedGoogle Scholar
  • 28 Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart 2013; 99 (15) 1118-1121
    CrossrefPubMedGoogle Scholar
  • 29 Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008; 31 (08) 1668-1669
    CrossrefPubMedGoogle Scholar
  • 30 Retnakaran R, Qi Y, Connelly PW, Sermer M, Zinman B, Hanley AJ. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010; 95 (02) 670-677
    CrossrefPubMedGoogle Scholar
  • 31 Stuebe AM, Landon MB, Lai Y. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD. Is there a threshold oral glucose tolerance test value for predicting adverse pregnancy outcome?. Am J Perinatol 2015; 32 (09) 833-838
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Kanauchi M, Kimura K, Kanauchi K, Saito Y. Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract 2005; 59 (04) 427-432
    CrossrefPubMedGoogle Scholar
  • 33 Abdul-Ghani MA, Lyssenko V, Tuomi T, Defronzo RA, Groop L. The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diabetes Metab Res Rev 2010; 26 (04) 280-286
    CrossrefPubMedGoogle Scholar
  • 34 Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003; 15 (06) 465-471
    CrossrefPubMedGoogle Scholar
  • 35 Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001; 86 (03) 989-993
    CrossrefPubMedGoogle Scholar
  • 36 Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 2011; 34 (07) 1582-1584
    CrossrefPubMedGoogle Scholar